You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0244: A Phase II Study of Two Different Induction Regimens of High Dose Carboplatin (Hdc) Vs Weekly Paclitaxel/Gemcitabine (Wpg) Followed By Pacli-Taxel/Carboplatin/Gemcitabine (Pcg) in Advanced Ovarian Cancer (Aoc)

Article info

Article menu
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0244: A Phase II Study of Two Different Induction Regimens of High Dose Carboplatin (Hdc) Vs Weekly Paclitaxel/Gemcitabine (Wpg) Followed By Pacli-Taxel/Carboplatin/Gemcitabine (Pcg) in Advanced Ovarian Cancer (Aoc)

Authors

Citation

Scarfone G, Polverino GP, Lorusso D, et al
0244: A Phase II Study of Two Different Induction Regimens of High Dose Carboplatin (Hdc) Vs Weekly Paclitaxel/Gemcitabine (Wpg) Followed By Pacli-Taxel/Carboplatin/Gemcitabine (Pcg) in Advanced Ovarian Cancer (Aoc)
International Journal of Gynecologic Cancer 2006;16:669.
Online issue publication 
October 01, 2006

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2006 IGCS, International Journal of Gynecological Cancer